Corbevax

Thursday, Apr 25, 2024 | Last Update : 11:04 AM IST

This will be in addition to the existing guidelines for homologous precaution dose administration of Covaxin and Covishield vaccine. (Representational image: ANI)

Corbevax approved as precaution dose for adults vaccinated with Covaxin, Covishield

This is for the first time that a booster dose that is different from the one used for primary vaccination against Covid has been allowed

10 Aug 2022 12:23 PM

The approval by the Drugs Controller General of India (DCGI) comes following recommendations by the Subject Expert Committee (SEC) on COVID-19 of the Central Drugs Standard Control Organisation(CDSCO). (AFP)

DCGI grants EUA to Corbevax for those aged 5-12, Covaxin for 6-12 age group

Authorisation given to Cadila for its ZyCoV-D for an additional dose of 3mg with a two-jab inoculation schedule for those aged above 12

26 Apr 2022 2:49 PM

A healthcare worker administers a dose of the Covid-19 preventive vaccine to a student at Lions Public School, in Gurugram, Wednesday, March 16, 2022. Vaccination for children in the age group of 12 to 14 years began on Wednesday. (PTI Photo)

Over 3 lakh doses of Covid vaccine given to children aged 12-14 yrs on day 1

As of March 1, 2021, there were 4.7 crore children aged 12 and 13 years in the country

17 Mar 2022 11:24 AM

The expected cost of the Corbevax vaccine is Rs 145 excluding taxes. (Photo: Biological E)

Biological E seeks EUA for COVID vaccine Corbevax for children aged 5-12: Sources

The Drugs Controller General of India (DCGI) is expected to give final EUA to Corbevax soo

09 Mar 2022 12:41 PM

Corbevax is India's first indigenously developed Receptor Binding Domain (RBD) protein sub-unit vaccine against COVID-19. (Photo: Biological E)

CDL Kasauli clears almost 6.5 crore doses of Corbevax: Sources

Corbevax is administered through the intramuscular route with two doses scheduled 28 days apart

22 Feb 2022 12:07 PM

EUA to Biological E's COVID-19 vaccine Corbevax for the 12 to 18 years age group, subject to certain conditions. (Representational Photo: PTI))

DCGI grants restricted EUA to Covid jab Corbevax for 12-18 age group

the government has not taken a decision yet on vaccinating those aged below 15 years

22 Feb 2022 12:18 AM

Corbevax is India's first indigenously developed Receptor Binding Domain (RBD) Protein sub-unit vaccine against the coronavirus infection. (Photo: Biological E/File)

Biological E's Corbevax vaccine granted approval for use in children aged 12-18

The move makes Corbevax the second covid vaccine to be approved for administration to children in India

21 Feb 2022 6:52 PM

Empty vials of Biological-E's covid vaccine Corbevax. (Photo: Biological-E/File)

Corbevax COVID vaccine is safe, offers high antibody levels: NTAGI chief

The remarks came after DCGI recommended Emergency Use Authorization to Biological E's vaccine, Corbevax

15 Feb 2022 2:53 PM

Empty vials of Biological-E's covid vaccine Corbevax. (Photo: Biological-E)

Discussions underway for WHO approval for Corbevax COVID-19 vaccine

Corbevax was recently granted emergency approval by the Indian govt and will be manufactured by Hyderabad-based Biological E

31 Dec 2021 9:13 AM

The government has also decided to provide precaution doses to all personnel deployed on election duty in the poll-bound states. (AP file image)

As COVID cases rise, govt gives nod to two more vaccines, anti-viral pill

With this approval, the number of Covid-19 vaccines which have received emergency use authorisation in the country has risen to eight

28 Dec 2021 11:41 AM

An experimental COVID-19 treatment pill, called molnupiravir is seen in this undated handout photo released by Merck & Co Inc. (Photo: AP)

SEC to take decision on antiviral Covid pill today

According to the sources, almost 10 pharma companies have completed clinical trials of antiviral pills

27 Dec 2021 1:37 PM

The Phase 3 trials are going to be a study in comparison with the already licensed vaccines, though the study in children is not a comparative study, she further said. (AFP Photo)

BE hopes to roll out COVID-19 vaccine Corbevax by November-end

Biological E's anti-coronavirus shot, Corbevax, is a RBD protein sub-unit vaccine and is ndergoing phase 2/3 clinical trials on adults

25 Oct 2021 4:57 PM

1 of 1

Columns

Dilip Cherian